Publications
- Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease - a multicentre retrospective-prospective observational study2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Transjugular intrahepatic portosystemic shunt (TIPS) own experiences in Radiodiagnostic Department of the University Hospital in Pilsen in the years 1997-20162018 | First Faculty of Medicine
- Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis2016 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
Loading network view...